Insulin enhances gene expression of Midnolin, a novel genetic risk factor for Parkinson's disease, via ERK, PI3-kinase and multiple transcription factors in SH-SY5Y cells.

Sagehashi N, Obara Y, Maruyama O, Nakagawa T, Hosoi T, Ishii K.

The Journal of Pharmacology and Experimental Therapeutics

2022-05

381

2

68

ENG

78

原著（フルペーパ投稿）